Market Newsdesk

Ketamine, originally approved by the FDA for anesthesia and pain relief, is now one of the psychedelics compounds being studied to treat mental health conditions like anxiety, addiction, and depression.

MIAMI, Dec. 23, 2020 (GLOBE NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, today announced it intends to offer home infusion of ketamine for patients whose healthcare provider has prescribed it as a treatment. Through its recently formed KetaDASH (www.ketadash.com) subsidiary, Ehave will provide medical professionals with the platform for home IV delivery. The platform will include software, protocols, and equipment, as well as a smart and intuitive dashboard for KetaDash designed to help patients and medical professionals interact.

Ehave Chief Executive Officer, Ben Kaplan, said, “The main reason we are focusing on ketamine as a psychedelic-assisted therapy is to present a new treatment for individuals suffering from depression, anxiety, PTSD or other mental or emotional health challenges. Our goal is to provide an IV service that will allow medical professionals to provide psychedelic-assisted therapies in the comfort and convenience of their patients’ homes. We believe a large number of patients prefer a medical technician come to their home over going to a clinic.”

Lisa Ling, who hosts “This is Life” on CNN, recently aired a special on the psychedelic treatment revolution and how ketamine has been successfully repurposed over the past few years to treat depression and PTSD. The report is available online at https://www.cnn.com/2020/12/20/opinions/psychedelics-trauma-healing-this-is-life-heacock/index.html.

Victor S. Dorodny, MD,ND,PHD,MPH (www.DrDorodny.com), Medical Advisor to Ehave, said, “Ketamine, a widely used anesthetic medication, is now being used to treat depression, suicidality, chronic pain, migraines, OCD and even some PTSD symptoms. For many, this breakthrough treatment represents a powerful opportunity to manage their mental health challenges. KetaDash will allow the patients who are prescribed Ketamine to receive required treatments in the safety and comfort of their homes.”

Additional Ehave Inc. Information

We are truly grateful for the support of EHVVF shareholders! Please join the conversation on our Ehave supporter’s telegram group at https://t.me/EhaveInc.

The company posts important information and updates through weekly videos from the official company YouTube channel https://www.youtube.com/channel/UCnyW1mgMd0qmYkEMq3O6FWA.

Please follow Ehave on Twitter @Ehaveinc1

About Ehave, Inc.

Ehave, Inc. (EHVVF) is a leader of digital therapeutics delivering evidence-based therapeutic interventions to patients. Our primary focus is on improving the standard care in therapeutics to prevent or treat brain disorders or diseases through the use of digital therapeutics, independently or together, with medications, devices, and other therapies to optimize patient care and health outcomes. Our main product is the Ehave Telemetry Portal, which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insights. The Ehave Infinity Portal offers a powerful machine learning and artificial intelligence platform with a growing set of advanced tools and applications developed by Ehave and its leading partners. This empowers patients, healthcare providers, and payers to address a wide range of conditions through high quality, safe, and effective data-driven involvement with intelligent and accessible tools. For more information visit: www.ehave.com.

About KetaDASH

KetaDash is a smart and intuitive dashboard designed for those giving and receiving Ketamine infusion therapy. Clients and the associated medical professionals can get detailed insight on the progress and effectiveness of the therapy. Patients can check the availability of nearby nurses, who can help them get their therapy in their own home. KetaDash lets you easily create your profile, check availability of the nurses, and schedule your appointment.

Patients and nurses, both can check the scheduled appointment details from their end. Also, when a client requests for a therapy, a nurse can accept or reject it depending on their availability. www.ketadash.com

Forward-Looking Statement Disclaimer

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the USA FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is contained under the heading “Risk Factors” in Ehave, Inc.’s Registration Statement on Form F-1 filed with the Securities and Exchange Commission (SEC) on September 24, 2015, as amended, which is available on the SEC’s website, http://www.sec.gov.

For Investor Relations, please contact:

Gabe Rodriguez

Phone: (623) 261-9046

Email: [email protected] 

FARMINGDALE, N.Y., Dec. 23, 2020 (GLOBE NEWSWIRE) — Misonix, Inc. (Nasdaq: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it will be participating in the 39^th Annual J.P. Morgan Healthcare Conference. Misonix Chief Executive Officer, Stavros Vizirgianakis, along with Joe Dwyer, Misonix Chief Financial Officer, will be making a virtual company presentation on Thursday, January 14^th at 3:40 p.m. ET. Management will also be available to speak with institutional investors in one-on-one virtual meetings throughout the day.

A live webcast of the presentation will be available on the Company’s web site at www.misonix.com.

If you have questions about Misonix or are interested in conducting a conference call or meeting with management, please contact the Company’s investor relations firm, JCIR, at (212) 835-8500 or via email at [email protected].

About Misonix, Inc.

Misonix, Inc. (Nasdaq: MSON) is a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. Its surgical team markets and sells Nexus, BoneScalpel, and SonaStar, which facilitate precise bone sculpting and removal of soft and hard tumors and tissue, primarily in the areas of neurosurgery, orthopedic, plastic and maxillo-facial surgery. The Company’s wound team markets and sells TheraSkin, Therion, TheraGenesis and SonicOne to debride, treat and heal chronic and traumatic wounds in inpatient, outpatient and physician office sites of service. At Misonix, Better Matters! That is why throughout the Company’s history, Misonix has maintained its commitment to medical technology innovation and the development of products that radically improve outcomes for patients. Additional information is available on the Company’s web site at www.misonix.com.

Contacts:
Joe Dwyer	Norberto Aja, Jennifer Neuman
Chief Financial Officer	JCIR
Misonix, Inc.	212-835-8500 or [email protected]
631-927-9113

BEVERLY HILLS, Calif., Dec. 23, 2020 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ:TOMZ), a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products – a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP), is pleased to showcase a highly-valued customer relationship with Merakey Behavioral Health.

Merakey provides education, support and therapy services in the areas of intellectual and developmental disability, behavioral health, autism, and addiction recovery to children and adults. It has locations in 12 states with a heavy concentration throughout Pennsylvania, placing great confidence in the SteraMist technology to safeguard their staff and patients in several facilities. TOMI’s Service Network (TSN) member, Enviro-Mist, utilizes SteraMist technology to treat 234,582 square feet across five Merakey campuses in Southeastern Pennsylvania on a quarterly basis.

Additionally, Merakey operations personnel treat their own facilities using five TOMI SteraMist Surface Unit disinfection devices, one for each facility. Merakey routinely treats more frequently with their units, as well as providing spot disinfection for suspected COVID-positive exposure and high traffic areas. These areas include common areas, dining areas, hallways, bathrooms, staff offices, nurse stations, and break areas.

The need for the SteraMist technology has never been greater, with medical facilities seeking a safeguard to act as a secure medical haven for patients experiencing mental health and behavioral challenges. Coronavirus has elevated disinfection protocols adopted by the medical community and will continue to evolve well beyond the pandemic, with further scrutiny placed on other harmful pathogens prevalent in medical environments such as MRSA, C. diff, and C. auris. With a second wave rise in COVID infection rates alongside the looming influenza season, diagnoses and medical treatments may be complicated and sheer volume may challenge healthcare structures.

Patient waiting rooms, lobby/common areas, clinical assessment, in-patient rooms, therapy and activity areas maintain hard deadline limitations for disinfection execution. SteraMist’s quick application, lack of toxic byproducts, and nonexistent residue creates the perfect solution to bring high traffic areas back into circulation quickly to avoid disrupting regular patient care.

Dr. Halden Shane, CEO of TOMI, stated that, “Not all COVID-19 disinfectants are created the same, and unlike a majority of the other options, SteraMist does not use harmful chemicals or damage the most delicate of electronics, equipment or fixtures. SteraMist is rooted in scientific evidence, developed under a DARPA grant and is the first ever EPA-registered Hospital-Healthcare and General Disinfectant equipment and solution combination. SteraMist can be trusted for its efficacy and non-caustic impact to patient care environments.”

TOMI™ Environmental Solutions, Inc.: Innovating for a safer world

^®
 

TOMI™ Environmental Solutions, Inc. (NASDAQ:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology^® (BIT^™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT^™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP^™). Represented by the SteraMist^® brand of products, iHP^™ produces a germ-killing aerosol that works like a visual non-caustic gas.

TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.

TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.

For additional information, please visit http://www.tomimist.com/ or contact us at [email protected].

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,” “projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.

INVESTOR RELATIONS CONTACT

John Nesbett/Jennifer Belodeau
IMS Investor Relations
[email protected]  

SHENZHEN, China, Dec. 23, 2020 (GLOBE NEWSWIRE) — Meten EdtechX Education Group Ltd. (Nasdaq: METX) (“Meten EdtechX” or the “Company”), a leading omnichannel English language training (“ELT”) service provider in China, today announced the latest business development of its exam preparatory product segments, demonstrating that the performance of the “BiGao” exam preparatory product (“BiGao”) for middle school students has exhibited strong growth since launch in July 2019. Meanwhile, with the launch of the “YunFan”, the exam preparatory product (“YunFan”) for college students, in December 2020, the competitiveness of Meten EdtechX in the market of exam preparatory products in China has been further strengthened.

With the core goal of improving students’ exam performance, “BiGao” provides a comprehensive VIP learning program for mid-to-high net worth families in China, covering various subjects, including English and mathematics ranging from the junior high school to the college entrance examination. Relying on the improving results from exam scores and good experiences, the cumulative gross billing generated from “BiGao” for the five months ended November 30, 2020 has been approximately RMB20 million, and has increased significantly by more than 360% compared to the same periods last year. It is worth noting that a significant number of the Company’s students from both online and offline ELT business segments are customers of “BiGao”, which enables “BiGao” to expand its customer base efficiently.

“YunFan” exam preparatory product was officially launched on December 22, 2020. Unlike “BiGao”, “Yunfan” is an exam preparatory product mainly designed to assist college students with their exam preparation, including high-level exams such as national English levels 4 and 6 and postgraduate entrance exams. The launch of “YunFan” enables the Company to expand its domestic exam preparatory product segments to different age groups and complete the close-loop of its business from ELT and domestic exam preparatory services in China to overseas exam preparation, which can effectively improve the conversion rate of the students of Meten EdtechX among different product lines and the user stickiness of the Company.

About Meten EdtechX

Meten EdtechX is a leading ELT service provider in China, delivering English language and future skills training for Chinese students and professionals. Through a sophisticated digital platform and nationwide network of learning centers, the Company provides its services under three industry-leading brands: Meten (adult and junior ELT services), ABC (primarily junior ELT services) and Likeshuo (online ELT). It offers superior teaching quality and student satisfaction, which are underpinned by cutting edge technology deployed across its business, including AI-driven centralized teaching and management systems that record and analyze learning processes in real time.

The Company is committed to improving the overall English language competence and competitiveness of the Chinese population to keep abreast of the rapid development of globalization. Its experienced management is focused on further developing its digital platform and expanding its network of learning centers to deliver a continually evolving service offerings to a growing number of students across China.

For more information, please visit: https://investor.metenedu-edtechx.com.

Safe Harbor Statement

This announcement contains forward-looking statements that involve risks and uncertainties. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the impact of the COVID-19 outbreak, our ability to attract students without a significant decrease in course fees; our ability to continue to hire, train and retain qualified teachers; our ability to maintain and enhance our “Meten” brand; our ability to effectively and efficiently manage the expansion of our school network and successfully execute our growth strategy; the outcome of ongoing, or any future, litigation or arbitration, including those relating to copyright and other intellectual property rights; competition in the English language training sector in China; changes in our revenues and certain cost or expense items as a percentage of our revenues; the expected growth of the Chinese English language training and private education market; Chinese governmental policies relating to private educational services and providers of such services; health epidemics and other outbreaks in China; and general economic conditions in China. Further information regarding these and other risks is included in our annual report on Form 20-F and other documents filed with the Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law. All information provided in this press release and in the attachments is as of the date of this press release, and the Company undertakes no duty to update such information, except as required under applicable law.

For investor and media inquiries, please contact:
Meten EdtechX
Wendy Wang
+86 136-5142-6060
[email protected]

Ascent Investor Relations LLC
Tina Xiao
+1 917-609-0333
[email protected]

MONTREAL, Dec. 23, 2020 (GLOBE NEWSWIRE) — Dominion Water Reserves Corp. (“DWR” or the “Company”) (CSE: DWR), is pleased to announce the appointment of Mr. Alexandre Côté as a Director of the Company. Mr. Côté joins the Board following the resignation of Mr. Quentin Yarie. The Company would like to thank Mr. Yarie for his contribution to the Company.

Mr. Côté is currently the Managing Director of Hybrid Financial. Prior to co-founding Hybrid Financial, Alexandre Côté was a Managing Director at AXA Canada where he helped create a Guaranteed Investment Funds platform. His team launched one of the first traditional fixed income funds listed in Canada. He also worked as VP of sales at OpenSky Capital, the largest independent marketer of structured products in Canada with over $3 billion in assets. As one of the first employees, he helped establish and develop the company. Mr. Côté started his career at Talvest, where he was responsible for a region with approximately $500 million of AUM. Mr. Cote earned a B.A. in Commerce from Laval University.

In addition, the Company announces that Mr. Andrew Lindzon has stepped down as CEO but will remain as a Director of the Company and will be replaced by Mr. Germain Turpin, a director and the current VP Finance of the Company, who will be the Interim CEO.

Mr. Turpin has 20 Years of experience in the Quebec water industry and in the former owner of two of the assets held by DWR. Germain’s sector knowledge combined with his experience as an operator will be major assets in the marketing and distribution of our renewed international assets, spring water, silicon water (13.2%) and water from the largest esker in Canada.

The Company also wishes to update that it has completed the previously announced transaction with Aquanor Inc. (“Aquanor”) (please see press release dated October 27, 2020) and issued 714,826 common shares, at a deemed issue price of $0.35, to Aquanor as partial consideration for the acquisition of all of the issued and outstanding securities of 11973002 Canada Inc. which owns a 100% interest in the St-Joseph de Coleraine water sources. The shares are subject to a hold period of four months and one day.

About Dominion Water Reserves Corp.

DWR’s operations are based in Quebec, with its primary business being a consolidator of the water industry by acquiring fresh spring water permits and developing operations across Quebec with plans to expand across North America. DWR currently controls more than 30% of Quebec’s volume of fresh groundwater reserves currently under permit and is strategically positioned to increase its holding. DWR’s mission is to acquire, manage and develop spring water assets building a critical mass in terms of capacity and strategically securing a leadership role in North America’s fresh spring water.  The corporation prioritizes sustainability and environmental consciousness. A strong governance structure is in place to ensure that the corporation carries out its business responsibly, applying the highest social and environmental standards.

For further information please contact

Jean Gosselin
Phone: 514-394-7717
Email: [email protected]

Neither the CSE nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Dominion Water Reserves Corp.

SPRINGDALE, Ark., Dec. 23, 2020 (GLOBE NEWSWIRE) — Tyson Foods, Inc. (NYSE: TSN) has named Megan Britt as the company’s new Vice President of Investor Relations.

Britt will be responsible for overseeing all aspects of investor relations, including shareholder communications, financial media relations and internet and intranet investor content. She begins her new role on January 4 and will report to Chief Financial Officer Stewart Glendinning.

Britt has almost 15 years of experience in roles in finance, including investor relations, investment management, decision analysis and corporate strategy. She most recently served as Vice President of Investor Relations for Corteva Agriscience, based in Wilmington, Delaware. Prior to her role at Corteva, she held various director roles at DuPont.

“We’re pleased to have Megan join our team as we continue to position Tyson Foods for long-term growth,” said Glendinning. “We believe her experience and leadership skills will be a great benefit to our investor relationships.”

“I’m looking forward to joining Tyson Foods and becoming part of a company with such a rich history and promising global future,” said Britt.

Britt holds a Bachelor of Science and Master of Agricultural and Applied Economics from Texas Tech University.

About Tyson Foods, Inc. 

Tyson Foods, Inc., (NYSE: TSN) is one of the world’s largest food companies and a recognized leader in protein. Founded in 1935 by John W. Tyson and grown under three generations of family leadership, the company has a broad portfolio of products and brands like Tyson®, Jimmy Dean®, Hillshire Farm®, Ball Park®, Wright®, Aidells®, ibp®, and State Fair®. Tyson Foods innovates continually to make protein more sustainable, tailor food for everywhere it’s available and raise the world’s expectations for how much good food can do. Headquartered in Springdale, Arkansas, United States, the company has 139,000 team members. Through its Core Values, Tyson Foods strives to operate with integrity, create value for its shareholders, customers, communities and team members and serve as a steward of the animals, land and environment entrusted to it. Visit WWW.TYSONFOODS.COM

Contact: Gary Mickelson, 479-236-9022

Category: IR, Newsroom

 

ROCHESTER, N.Y., Dec. 23, 2020 (GLOBE NEWSWIRE) — Document Security Systems, Inc. (NYSE American: DSS), a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced its wholly owned subsidiary Impact BioMedical, Inc. (“Impact BioMedical”) entered into a 10-year exclusive distribution agreement (the “Distribution Agreement”) with BioMed Technology Asia Pacific Holdings Limited (“BioMed”), a limited liability company incorporated in the British Virgin Islands. BioMed is the holding company of BioMed Technology Holdings Limited which focuses on manufacturing natural probiotics, pursuant to which the Company will directly market, advertise, promote, distribute and sell certain BioMed products to resellers. The products to be distributed by the Company include BioMed’s PGut Premium Probiotics^®, PGut Allergy Probiotics^®, PGut SupremeSlim Probiotics^®, PGut Kids Probiotics^®, and PGut Baby Probiotics^®.

Under the terms of the Distribution Agreement, the Company will have exclusive rights to distribute the products within the United States, Canada, Singapore, Malaysia, and South Korea and non-exclusive distribution rights in all other countries. In exchange, the Company agreed to certain obligations, including mutual marketing obligations to promote sales of the products.

“We are pleased to have secured exclusive distribution rights to key major markets globally,” stated Chan Heng Fai, Chairman of DSS. “This latest agreement further strengthens Impact BioMedical’s foundation and provides the potential for strong near-term revenue growth. We look forward to providing further updates on this and other initiatives as we continue to execute.”

The global probiotics market was estimated at US$48 billion in 2018 and is anticipated to expand at a CAGR of 6.9% through 2025, driven by the growing consumer inclination towards preventive healthcare in conjunction with the development of efficient probiotic strains.
         
In connection with the Distribution Agreement, the Company also entered into a subscription agreement with BioMed (the “Subscription Agreement”), pursuant to which the Company agreed to purchase 525 ordinary shares of BioMed (the “Shares”) at a purchase price of HK$9,333.33 per share for total consideration of HK$4,900,000 (approximately US$630,000).

The Subscription Agreement provides, among other things, the Company the right to appoint a new director to the board of BioMed. With respect to an issuance of shares to a third party by BioMed, the Company will have the right of first refusal to purchase such shares, as well as customary tag-along rights.

About Impact BioMedical, Inc.

Impact BioMedical, Inc. (“Impact BioMedical”) is a wholly owned subsidiary of DSS. Impact BioMedical strives to leverage its scientific know-how and intellectual property rights to provide solutions that have been plaguing the biomedical field for decades. By tapping into the scientific expertise of GRDG Sciences, LLC, Impact BioMedical pledges to undertake a concerted effort in the R&D, drug discovery and development for the prevention, inhibition, and treatment of neurological, oncological and immuno related diseases. For more information on Impact BioMedical visit http://impbio.com/.

About Document Security Systems, Inc.

DSS is a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets. Its business model is based on a distribution sharing system in which shareholders will receive shares in its subsidiaries as DSS strategically spins them out into IPOs. Its historic business revolves around counterfeit deterrent and authentication technologies, smart packaging, and consumer product engagement. DSS is led by its Chairman and largest shareholder, Mr. Fai Chan, a highly successful global business veteran of more than 40 years specializing in corporate transformation while managing risk. He has successfully restructured more than 35 corporations with a combined value of $25 billion.

For more information on DSS visit http://www.dsssecure.com.

Investor Contact:

Dave Gentry, CEO
RedChip Companies Inc.
407-491-4498
[email protected]

Safe Harbor Disclosure

This press release contains forward-looking statements that are made pursuant to the safe harbor provisions within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, but are not limited to, statements related to the Company’s intended use of proceeds and other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that may cause actual results or events to differ materially from those projected. These risks and uncertainties, many of which are beyond our control, include: risks relating to our growth strategy; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; risks relating to the results of development activities; our ability to attract, integrate and retain key personnel; our need for substantial additional funds; patent and intellectual property matters; competition; as well as other risks described in our SEC filings, including, without limitation, our reports on Forms 8-K, 10-K and 10-Q, all of which can be obtained on the SEC website at www.sec.gov. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management’s current estimates, projections, expectations and beliefs. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

Consumers Now Can Escape Their Quarantine Realities & Make New Year’s Eve Plans, As Loop Media & Ultimate Gamer Kick Off Their Partnership With An Innovative New “Virtual New Year’s Eve” Immersive Experience 

Glendale, CA, Dec. 23, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Loop Media, Inc. (“Loop Media”), the first media company that gives consumers and businesses fully-integrated 360-degree and other premium short-form content experiences (OTC: LPTV), will kick off its partnership with Ultimate Gamer, the world’s first and only multi-genre esports proving ground, on Virtual New Year’s Eve (VNYE), a brand new, immersive experience that will bring the world of Times Square to everyone, everywhere.

Times Square will be empty this New Year’s Eve for the first time since the ceremony’s inception in 1907 due to rising COVID-19 infection rate concerns. Jamestown—the real-estate investment and management company that owns One Times Square—has planned a New Year’s Eve celebration blending virtual and augmented experiences with live camera feeds, which is totally free. Users can download the “VNYE” app or sign in to VNYE.com.

As an exclusive gaming partner, Ultimate Gamer will provide unique virtual experiences, interactive content, and streams geared toward gamers and esports fans through the app and website. 

From December 19th, 2020 – January 3rd, 2021, Ultimate Gamer will host a variety of streams on VNYE, featuring popular esports teams like Misfits Gaming and Team Furia; gaming personalities including HipHopGamer and Jobless Gamer; and entertainment from NBA2K content creators HankDaTank, BreeZe, ColeTheMan, and Hollywood, among others. Throughout the two weeks, Ultimate Gamer will host Fortnite, Valorant, Apex Legends, and League of Legends competitions with fun prizes and giveaways leading up to New Year’s Eve.

Also included within the Ultimate Gamer experience will be curated music videos, courtesy of Loop Media. Loop Media’s video library includes not only one of the largest and most current collection of music videos, but also film and game trailers, as well as sports highlights that provide a variety of engaging product offerings to users. The Loop™ app is available to consumers on iPhone and Android, as well as all popular connected TVs including Amazon Fire TV and Android TV-supported sets such as Sony, Sharp, Philips, and more.

About Loop Media

Loop Media, Inc is the first media company that gives consumers and businesses fully-integrated 360-degree and other premium short-form content experiences. Loop improves the entire viewing experience for premium short-form content by focusing on venues and consumers in the evolving frontier of digital out-of-home, streamlining the public-to-private viewing experience. Loop’s growing library of over 500,000 short-form videos, including: music videos, film, game and TV trailers, viral videos, sports clips and atmospherics and travel videos can be viewed in many popular hospitality, dining, and retail venues; on leading branded media and entertainment sites; and on over-the-top TV platforms and CTV devices. To learn more about Loop products and applications, please visit us online at Loop.tv

About Ultimate Gamer

Ultimate Gamer is where the world comes to play. With over 2 million registered users, the company is on a mission to build the world’s largest community of gamers. In 2021, Ultimate Gamer will launch a premier worldwide competition to identify and crown the ‘Best Gamer on Earth™’ and award a $1 million prize. As the first and only multi-genre esports and gaming proving ground, Ultimate Gamer is focused on bringing gamers of all skill levels together. For more information on how to get involved, please visit ultimategamer.com.

Loop Media, Inc. Press:

Jon Lindsay Phillips
RLM PR
[email protected]
+1-646-828-8566 

Ultimate Gamer Press:

Kalie Moore
High Vibe PR
[email protected] 

MONTREAL, Dec. 23, 2020 (GLOBE NEWSWIRE) — Imperial Mining Group Ltd. (“Imperialˮ or the “Corporation”) (TSX VENTURE: IPG) is pleased to announce that it closed a non-brokered private placement today (the “Offering”) of 19,623,672 shares on a “flow-though” basis at a price of $0.11 per share and 5,262,500 units (each, a “Unit”) at a price of $0.08 per Unit. Each Unit is comprised of one (1) common share (each a “Share”) and half (1/2) of a Share purchase warrant, with each warrant entitling the holder to acquire one (1) additional Share of the Corporation at a price of $0.12 over a period of 24 months from the closing date.

The Corporation was able to raise a total of $2,579,604.16 in the Offering, $2,158,604.16 in shares and $421,000.00 in Units.

The Corporation will use the proceeds of the Offering to complete definition drilling of the Corporation’s Crater Lake TG Zone scandium-rare earth target and to deliver both a 43-101 Resource Report and a Preliminary Economic Assessment (PEA) by the end of H1 2021 and for other corporate purposes.

“I am very pleased of the positive response that the market has shown for our private placement,” said Imperial President & CEO, Peter Cashin. “The financing was oversubscribed, and we believe that it was motivated by the recent significant announcements in the critical metal space, in particular for scandium and the rare earths. The recognition by manufacturers in the automotive, aerospace, and defense sectors that scandium-modified aluminum alloy materials will become critical inputs into their platforms is an important development. This is particularly so, given the strength of Quebec’s aluminum industry, that scandium-aluminum alloys will become an important value-added product for the province’s aluminum industry.”

In connection with the Offering, the Corporation paid to finders, which are all at arms’ length with the Corporation, finders’ fees for a total of $95,898.28 in cash and issued 890,073 warrants, with each warrant entitling the holder to acquire one (1) Share of the Corporation at a price of $0.12 over a period of 24-months from the closing date.

All securities issued pursuant to the Offering are subject to the applicable statutory hold period of four months and one day from the closing. The Offering is subject to the final approval of the TSX Venture Exchange.

ABOUT IMPERIAL MINING GROUP LTD.

Imperial is a new Canadian mineral exploration and development company focussed on the advancement of its copper-zinc, gold and technology metals properties in Québec. Imperial is publicly listed on the TSX Venture Exchange as “IPG” and is led by an experienced team of mineral exploration and development professionals with a strong track record of mineral deposit discovery in numerous metal commodities.

For further information please contact:

Peter J. Cashin President and Chief Executive Officer Phone: +1 (514) 360-0571 Email:[email protected]

CHF Capital Markets Iryna Zheliasko, Manager-Corporate Communications Phone: +1 (416) 868-1079 x229 Email:iryna@chfir.com

Website:
www.imperialmgp.com          Twitter: @imperial_mining         Facebook:Imperial Mining Group

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

PsychedelicSpotlight.com upgrades website for user experience and increased content

Las Vegas, Nevada, Dec. 23, 2020 (GLOBE NEWSWIRE) — Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that the Company has launched a new web platform for its Psychedelic Spotlight web magazine. 

The new site is part of the continued growth Psychedelic Spotlight is experiencing. In Q4 of 2020 a record number of new users visited the site, breaking page view records.

“When PSYC initially launched Psychedelic Spotlight last spring I’m not sure if anyone could fathom how quickly it would grow into one of the most prominent sources for news, information, and resources within the sector of medicinal psychedelics,” said David Flores, Global Trac Solutions, Inc. CEO. “The new site will present a sleeker and more appealing visual experience for our audience. However, some of the most important and beneficial updates and changes we have infused the site with are on the backend. This new site has been developed with SEO and Google ranking analytics in mind in order to more effectively position it to capture as much of the growing audience within this sector as possible.” 

“I’m thrilled to bring this new platform to our readers,” said Jill Ettinger, Psychedelic Spotlight’s Director of Content. “They keep telling us how much they love the content at Psychedelic Spotlight, and now we have a platform that’s only going to add to that positive experience as well as sustain its continued growth and expansion in the months ahead.” 

The Company, through its digital media marketing partner, SunCity Advising, expects to rollout additional pages and features for the Psychedelic Spotlight website over the next several weeks in its ongoing mission of delivering the most resourceful and content-rich web platform in the sector of medicinal psychedelics.

About Global Trac Solutions, Inc. (OTCPink: PSYC)

At Global Trac Solutions we are integrating media, creativity, and technology to develop and deploy thought-provoking ideas and solutions that are fostering and transforming the approach to some of society’s most pressing matters.

PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.

We believe in a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future. We truly are the right TRAC to follow.

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors, including the effect of COVID-19, that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website.

Disclaimer: Global Trac Solutions, Inc. does not in any way encourage or condone the use, purchase, sale or transfer of any illegal substances, nor do we encourage or condone partaking in any unlawful activities. We support a harm reduction approach for the purpose of education and promoting individual and public safety. If you are choosing to use psychedelic substances, please do so responsibly.

Corporate Contact:

Global Trac Solutions, Inc. (PSYC)
www.globaltracsolutions.com
(702) 239-1919
[email protected]
OTCPINK: PSYC